1. Home
  2. SW vs BNTX Comparison

SW vs BNTX Comparison

Compare SW & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smurfit WestRock plc Ordinary Shares

SW

Smurfit WestRock plc Ordinary Shares

HOLD

Current Price

$39.85

Market Cap

20.3B

Sector

N/A

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$89.07

Market Cap

22.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SW
BNTX
Founded
1934
2008
Country
Ireland
Germany
Employees
97000
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3B
22.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SW
BNTX
Price
$39.85
$89.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
13
Target Price
$54.25
$134.15
AVG Volume (30 Days)
5.4M
1.3M
Earning Date
04-30-2026
03-10-2026
Dividend Yield
4.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.53
N/A
Revenue Next Year
$2.94
$4.76
P/E Ratio
$38.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.73
$79.81
52 Week High
$52.65
$124.00

Technical Indicators

Market Signals
Indicator
SW
BNTX
Relative Strength Index (RSI) 45.17 41.97
Support Level $36.00 $79.81
Resistance Level $44.38 $114.06
Average True Range (ATR) 1.43 2.46
MACD 0.10 0.10
Stochastic Oscillator 65.93 42.76

Price Performance

Historical Comparison
SW
BNTX

About SW Smurfit WestRock plc Ordinary Shares

Smurfit WestRock PLC manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. operates a vertically integrated system supplying wood and recovered fiber to produce various grades of board, which are then converted into packaging products. Its main packaging categories include corrugated containers and consumer packaging, with additional products such as solidboard, kraft paper, graphic board, paper sacks, and bag-in-box packaging. The company's geographical segments include North America (including the U.S., Canada and Mexico), Europe, the Middle East and Africa and Asia-Pacific, and Latin America. The majority of the company's revenue is derived from product sales in the North American region.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: